KAFILAT OJO: Open Payments
NPI 1083020119 · EWING, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 5 payments from 4 companies in 2025. Trend: 2023 $145 · 2024 $639 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $219 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| Janssen Pharmaceuticals, Inc | 1 | $120 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
Products named: REXULTI, INGREZZA, SPRAVATO, COBENFY.
Industry payments across NJ — which companies pay providers there.
